Introduction to Treat the Pain. The problem of unrelieved pain Globally, 7.3 million people die of cancer or HIV each year in moderate or severe pain.

Slides:



Advertisements
Similar presentations
Strategies to strengthen the distribution system to improve the availability of medicine Dr Wael Inmair Director Assistant, Central Medical Supply Store,
Advertisements

Our vision is a world free from TB. Our mission is to address the health, social and economic impact of the global TB epidemic amongst vulnerable and.
State Health Departments: Focused on the Next Level Ann Robbins Texas Department of State Health Services National Alliance of State and Territorial AIDS.
"3 by 5" progress December 2005 Progress on global access to HIV antiretroviral therapy | 12 April |2 | Antiretroviral therapy coverage in low-
Global Campaign on Social Security and Coverage for All Progress Report March 2004.
TB and HIV: Tightly Linked… and Why We Should Care.
PSK Annual Conference 2008 Palliative care medicine: A balanced approach to opioid availability and safe use in Kenya Presenter: Dr. Bilha Kiama-Murage.
00003-E-1 – December 2004 Global summary of the HIV and AIDS epidemic, December 2004 The ranges around the estimates in this table define the boundaries.
Slide 2 Key Points Although HIV/AIDS is found throughout the world, most people living with HIV/AIDS reside in low- and middle-income countries More people.
00002-E-1 – 1 December 2003 Global summary of the HIV/AIDS epidemic, December 2003 The ranges around the estimates in this table define the boundaries.
UNAIDS World AIDS Day Report | 2011 Core Epidemiology Slides.
Public-Private Mix (PPM) for TB Control in Global Fund grants Scope and significance SS Lal *, Mukund Uplekar #, Itamar Katz*, Knut Lonnroth #, Ryuichi.
Situation analysis in Kyrgyzstan Making Opioids Available in Eastern Europe and Central Asia March 5-6, 2013 Vienna.
HIV Therapy for the Developing World: A Global Health Challenge Harold W. Jaffe, MD Department of Public Health University of Oxford Oxford, UK.
Global Response to HIV/AIDS Nigerian Nurses Association of USA June 30, 2006 Carolyn M Hall, MSN/MPH, ACRN Global HIV/AIDS Program U.S. Department of Health.
Contents of the presentation OST programme in SA region - Current scenario Scaling up OST in SA region Supply chain management.
1 July 2008 e Global summary of the AIDS epidemic, December 2007 Total33 million [30 – 36 million] Adults30.8 million [28.2 – 34.0 million] Women15.5 million.
DON’T FORGET THE ‘E’ IN “MORPHINE” International Pain Policy Fellowship: Advocacy & Communications.
The Global Fund- structure, function and evolution February 18, 2008.
Antiretroviral Treatment (ART) & Human resources Wim Van Damme Department of Public Health ITM, 17 October 2006.
PARIS21 Partnership in Statistics for Development in the 21st Century Strategic planning for a better integration of sectors within NSS High Level Meeting.
1 Manual Vacuum Aspiration Case Study Matthew Reeves, MD, MPH RHSC Membership Meeting 24 June 2011 Addis Ababa, Ethiopia.
Understanding and Using INCB Opioid Consumption Statistics: Including Morphine Equivalence 8 August 2012 Martha Maurer, MSW, MPH, PhD Pain & Policy Studies.
Improving Access and Quality Use of Medicines in Palliative Care within National Drug Policy, Regulatory, and Funding Frameworks Debra Rowett, Tania Shelby-James,
Global Access to Pain Relief Initiative (GAPRI) Meg O’Brien 1 Market Forecast in Eastern Europe and Central Asia March 2013.
Overviews of the Drug Distribution System & Barriers to Opioid Availability Dr. Bishnu Dutta Paudel International Pain Policy Fellowship Training Program.
ACCESS TO MEDICINES - POLICY AND ISSUES
Institut Català d’Oncologia ICO DiR. The ‘Qualy’ End of Life Care Observatory - WHO Collaborating Centre for Public Health Palliative Care Programmes Central.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
Tajikistan Making Opioids Available in Eastern Europe and Central Asia March 5-6, 2013 Vienna.
Methods to Evaluate and Improve National Policy: Focus on 2011 WHO Guidelines and PPSG Global Policy Evaluation Aaron M. Gilson, MS, MSSW, PhD Research.
Meg O’Brien, Ph.D. Director, Global Access to Pain Relief Initiative Procurement & Manufacture of IR Oral Morphine: Uganda experience 1.
“” “Balance” Jim Cleary, MD Associate Professor of Medicine Director, Palliative Care Medicine, UW Hospital & Clinics Director, WHO Collaborating Center.
00003-E-1 – December 2005 Global summary of the HIV and AIDS epidemic, December 2005 The ranges around the estimates in this table define the boundaries.
2004: 39.4 (35.9 – 44.3) million Western & Central Europe [ – ] North Africa & Middle East [ – 1.5 million] Sub-Saharan.
Global Challenges in Cancer Pain S. Lawrence Librach MD,CCFP,FCFP Professor, Department of Family & Community Medicine Sun Life Financial Chair & Director,
Ensuring Availability and Preventing Diversion International Pain Policy Fellowship August 7, 2012 David E. Joranson University of Wisconsin Pain & Policy.
WORLD ALLIANCE OF YMCAS ASIA AND PACIFIC ALLIANCE OF YMCAS (APAY) GENERAL ASSEMBLY – SEPTEMBER 2011.
00002-E-1 – 1 December 2003 Adults and children estimated to be living with HIV/AIDS as of end 2003 Total: 34 – 46 million Western Europe – 680.
HIV AND INFANT FEEDING A FRAMEWORK FOR PRIORITY ACTIONS.
The Global HIV/AIDS Epidemic Jennifer Kates, M.A., M.P.A. Vice President and Director, HIV Policy Kaiser Family Foundation KaiserEDU.org Tutorial April.
Scaling up access to antiretroviral therapy in low- and middle-income countries: global and regional progress in 2008 Yves Souteyrand HIV/AIDS Department,
Multi-country study on drug supply and distribution activities of faith-based supply organizations in sub-Saharan African countries, 2003 Sophie Logez.
00002-E-1 – 1 December 2001 Global summary of the HIV/AIDS epidemic, December 2001 Number of people living with HIV/AIDS Total40 million Adults37.2 million.
1 Total 33.2 million [30.6 – 36.1 million] Adults 30.8 million [28.2 – 33.6 million] Women 15.4 million [13.9 – 16.6 million] Children under 15 years 2.5.
00002-E-1 – 1 December 2002 Global summary of the HIV/AIDS epidemic, December 2002 Number of people living with HIV/AIDS Total42 million Adults38.6 million.
Quality Care Standards Authors: Frokjaer B, Grant RL Problem Statement: All practicing pharmacists are obliged to ensure that the service they provide.
The Bank’s Regional HIV/AIDS Strategies An Overview.
ADDRESSING PHARMACEUTICAL SUPPLY CHAIN NEEDS PRESENTATION TO HEALTH DONOR GROUP MEETING 8 July 2009.
Number of people living with HIV on antiretroviral therapy, global, 2010–2015
1 July 2008 e Global summary of the AIDS epidemic, December 2007 Total33 million [30 – 36 million] Adults30.8 million [28.2 – 34.0 million] Women15.5 million.
1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)
Global Impact of HIV/AIDS Deborah Lewinsohn, M.D. Infectious Diseases, Pediatrics Vaccine and Gene Therapy Institute Oregon Health & Science University.
The Global Fund 19 th Board Meeting Geneva, 4 May 2009 Technical Assistance Hind Khatib-Othman Director Eastern Europe & Central Asia, Latin America and.
EAST AFRICAN COMMUNITY MEDICINES REGULATORY HARMONIZATION (EAC-MRH) PROJECT PROGRESS NAIROB I - KENYA By: EAC - Secretariat.
Estimated number of new HIV infections in young people
Expanding ARV treatment in developing countries: Issues and Prospects
World Health Organization
Global epidemiology of injecting drug use
HIV Response Funding Trends 10:30 am to 12:00 pm
"3 by 5" progress December 2005.
Indispensable, adequately provided and not unduly restricted
Estimated adult and child deaths from AIDS  2009
Western & Central Europe
Global summary of the HIV and AIDS epidemic, 2005
Regional HIV and AIDS statistics 2008 and 2001
Children (<15 years) estimated to be living with HIV as of end 2005
Opioids Market Research Report – Global Forecast till 2023 Global Industry Survey, Growth, Competitive Landscape and Forecasts to 2023 CREATED BY Market.
Global summary of the HIV and AIDS epidemic, 2005
Situation analysis in Kyrgyzstan
Presentation transcript:

Introduction to Treat the Pain

The problem of unrelieved pain Globally, 7.3 million people die of cancer or HIV each year in moderate or severe pain More than 2.9 million die without pain relief 99.9% of these deaths are in low and middle-income countries 2 Source: 2010 WHO cause of death and INCB reports (

There are 2.9 million deaths from HIV or cancer in untreated pain each year Sub-Saharan Africa: 41% South Asia: 29% East Asia & Pacific: 16% Europe & Central Asia, Latin America & Caribbean, Middle East & North Africa, North America: 14% Scoping the problem 3 Source: 2010 WHO cause of death and INCB reports ( Untreated deaths in pain

44 Low and middle-income countries 70% of cancer deaths 99% of HIV deaths just 7% of medicinal opioids US, Canada, UK, Australia 11% of cancer deaths <1% of HIV deaths 67% of medicinal opioids There is a great disparity in access to pain relief

Untreated deaths in pain 5 60% of the unmet need is in 10 countries Source: 2010 WHO cause of death and INCB reports ( * * * * Denotes GAPRI partner countries

9% 12% Untreated deaths in pain Progress against goals 2010: 2.9 million untreated deaths in pain and going down Global coverage rate is 60% 100%-high income 57%-middle income 8%-low income 6

Goal Objectives Strategy 1. Strengthen government leadership by providing staff (fellows) and technical assistance directly to health ministries 2. Reduce cost and improve availability of medicines by negotiating with suppliers and providing technical assistance to buyers 3. Improve clinical and regulatory policies and practice by advocating on international, national, and facility levels 4. Improve skills and motivation of individual clinicians by improving access to information and to other clinicians interested in pain treatment Develop high-profile projects in countries with large unmet need; prompt change in neighboring countries and adoption by other organizations Universal access to essential pain medicines by Global Access to Pain Relief Initiative (GAPRI)

National Agency for Food and Drug Administration and Control (NAFDAC), with input from Federal Ministry of Health (FMOH), submits annual estimate to International Narcotics Control Board (INCB) INCB approves morphine quantity MOH Pharmacy Dept places order with international supplier and NAFDAC approves importation Drugs received by Central Medical Stores in Lagos Registered pharmacist, on behalf of a health facility, gets approval from Central Medical Stores Lagos Powder is reconstituted into solution Clinician asks about pain Patient reports pain Clinician writes prescription Patient fills prescription Patient receives monitoring and follow-up Nigeria: 3 kg What does it take to get morphine in Nigeria? Registered pharmacist, on behalf of a health facility, gets approval from state MOH Registered pharmacist picks up drugs at Central Medical Stores Lagos Mechanism of access 8

National Agency for Food and Drug Administration and Control (NAFDAC), with input from Federal Ministry of Health (FMOH), submits annual estimate to International Narcotics Control Board (INCB) INCB approves morphine quantity MOH Pharmacy Dept places order with international supplier and NAFDAC approves importation Drugs received by Central Medical Stores in Lagos Registered pharmacist, on behalf of a health facility, gets approval from Central Medical Stores Lagos Powder is reconstituted into solution Clinician asks about pain Patient reports pain Clinician writes prescription Patient fills prescription Patient receives monitoring and follow-up Nigeria: 3 kg Why isn’t it working? Registered pharmacist, on behalf of a health facility, gets approval from state MOH Registered pharmacist picks up drugs at Central Medical Stores Lagos MOH is not ordering; last order expired before use Users did not know morphine was available Approvals took a very long time; required several days in Lagos Difficult for facilities far from Lagos Limited capacity for reconstitution outside of large facilities; lack of quality control Lack of awareness from patients; lack of trained clinicians Patients pay for drugs 9

National Agency for Food and Drug Administration and Control (NAFDAC), with input from Federal Ministry of Health (FMOH), submits annual estimate to International Narcotics Control Board (INCB) INCB approves morphine quantity MOH Pharmacy Dept places order with international supplier and NAFDAC approves importation Drugs received by Central Medical Stores in Lagos Registered pharmacist, on behalf of a health facility, gets approval from Central Medical Stores Lagos Powder is reconstituted into solution Clinician asks about pain Patient reports pain Clinician writes prescription Patient fills prescription Patient receives monitoring and follow-up Nigeria: 3 kg What can GAPRI do? Registered pharmacist, on behalf of a health facility, gets approval from state MOH Registered pharmacist picks up drugs at Central Medical Stores Lagos MOH is not ordering; last order expired before use Users did not know morphine was available Approvals took a very long time; required several days in Lagos Difficult for facilities far from Lagos Limited capacity for reconstitution outside of large facilities; lack of quality control Lack of awareness from patients; lack of trained clinicians Patients pay for drugs Drug forecast and stock monitoring Supplier identification and negotiation Communication of availability Streamline approvals Track and monitor stocks Integrate pain treatment into HIV and cancer care Collaborate with NGOs to improve awareness Improve distribution 10

11 GAPRI Fellowship Program: Nigeria Three-year partnership with the Federal Ministry of Health (FMOH) Placed a consultant in the Department of Food and Drug Services, FMOH as Special Assistant to the Director for Access to Pain Relief Procured first batch of morphine in 4 years, improving distribution, training clinicians Working with HIV and cancer communities to integrate pain relief Population: 155 million Deaths in pain: 177,000 Coverage: <1%

Supply Project: Uganda 12 In 2010 GAPRI negotiated a deal between government and an NGO to create a national morphine production program Government certified production facility at Hospice Africa Uganda now producing morphine for the entire country Current cost is 2 USD for a week of treatment – reducing the government’s cost by 40% Increased stability of supply and expanded patient access Morphine is now free for all patients Population: 33 million Deaths in pain: 69,000 Coverage: 4%

13 Pain Free Hospital Initiative: India A one-year hospital-wide quality improvement initiative in 3 hospitals  Improve knowledge and skills to assess and treat pain  Raise awareness about untreated pain  Improve availability of essential pain medicines  Measure and document activities and their impact GAPRI is working with partners in India to implement the Pain-Free Hospital Initiative Population: 1.2 billion Deaths in pain 694,000 Coverage: 11%